LuCAS-Plus
Monitor Corporation
| Product specifications |
Information source:
Vendor
Last updated: March 23, 2022 |
| General | |
|---|---|
| Product name | LuCAS-Plus |
| Company | Monitor Corporation |
| Subspeciality | Chest |
| Modality | CT |
| Disease targeted | Lung cancer |
| Key-features | Nodule detection and localization, nodule characterization, nodule quantification, segmentation and measurement, longitudinal follow-up |
| Suggested use | During: perception aid (prompting all abnormalities/results/heatmaps) |
| Data characteristics | |
| Population | Asymptomatic population, all ages |
| Input | 3D, constrast, non-contrast, CT, low-dose CT |
| Input format | DICOM |
| Output | Nodule coordinate, nodule segmentation, nodule size, nodule type, nodule location, nodule change |
| Output format | DICOM |
| Technology | |
| Integration | Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration CIS (Clinical Information System), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
| Deployment | Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution |
| Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
| Processing time | 1 - 10 minutes |
| Certification | |
|
CE
|
Certified,
Class IIa
, MDD
|
|
FDA
|
No or not yet |
| Market presence | |
| On market since | 07-2020 |
| Distribution channels | |
| Countries present (clinical, non-research use) | 1 |
| Paying clinical customers (institutes) | 0 |
| Research/test users (institutes) | 2 |
| Pricing | |
| Pricing model | Pay-per-use, Subscription, One-time license fee |
| Based on | Number of users, Number of installations, Number of analyses |
| Evidence | |
| Peer reviewed papers on performance | |
| Non-peer reviewed papers on performance | |
| Other relevant papers | |